The invention relates to medicine and can be used for treating a range of diseases in the treatment of which interferon is used. The agent for inducing endogenous interferon is comprised of the compound 6-(3-methoxycarbonyl phenyl) amino-2,4 (1H,3H)-pyrimidinedione C12H11N3O4 of general formula: (I). The preparation exhibits greater activity both when injected and when administered orally.
本发明涉及医药,可用于治疗一系列使用干扰素的疾病。诱导内源性干扰素的药剂由通式为 6-(3-甲氧羰基苯基)
氨基-2,4(1H,3H)-
嘧啶二酮
C12H11N3O4 的化合物组成:(I).该制剂在注射和口服时均表现出更强的活性。